Nitric oxide-cyclic GMP signaling in stem cell differentiation
- PMID: 22019632
- PMCID: PMC3232180
- DOI: 10.1016/j.freeradbiomed.2011.09.037
Nitric oxide-cyclic GMP signaling in stem cell differentiation
Abstract
The nitric oxide-cyclic GMP (NO-cGMP) pathway mediates important physiological functions associated with various integrative body systems including the cardiovascular and nervous systems. Furthermore, NO regulates cell growth, survival, apoptosis, proliferation, and differentiation at the cellular level. To understand the significance of the NO-cGMP pathway in development and differentiation, studies have been conducted both in developing embryos and in stem cells. Manipulation of the NO-cGMP pathway, by employing activators and inhibitors as pharmacological probes, and genetic manipulation of NO signaling components have implicated the involvement of this pathway in the regulation of stem cell differentiation. This review focuses on some of the work pertaining to the role of NO-cGMP in the differentiation of stem cells into cells of various lineages, particularly into myocardial cells, and in stem cell-based therapy.
Published by Elsevier Inc.
References
-
- Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol. 1996;271:C1424–C1437. - PubMed
-
- Bryan NS, Bian K, Murad F. Discovering of nitric oxide signaling pathways and targets for drug development. Front Biosci. 2009;14:1–18. - PubMed
-
- Murad F. Shattuck Lecture: Nitric oxide and cyclic GMP in cell signaling and drug development. New Engl J Med. 2006;355:2003–2011. - PubMed
-
- Moncada S, Palmer RMJ, Higgs J. Nitric Oxide; physiology, patho-physiology and pharmacology. Pharmacol Rev. 1991;43:109–142. - PubMed
-
- Xia H, Bredt DS. Cloned and expressed nitric oxide synthase proteins. Methods Enzymol. 1996;268:427–436. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
